|
Melekhina E.V., Muzyka A.D., Ponezheva Zh.B., Gorelov A.V.
Herpesvirus infections in the works of the Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
|
№2 / 2023
|
|
Solomay T.V., Semenenko A.V., Nikitina G.Yu., Shuvalov A.N.
Predictive scenarios for the development of the epidemic process of Epstein-Barr virus infection in the absence of specific prevention measures and their implementation
|
№1 / 2023
|
|
Solomay T.V., Semenenko T.A., Isaeva E.I., Vetrova E.N.
The role of active Epstein–Barr viral infection in the development of cerebrovascular diseases
|
№2 / 2022
|
|
Permyakova A.V., Sazhin A.V., Melekhina E.V., Gorelov A.V.
Possibilities of biological and mathematical modeling of infection caused by Epstein–Barr virus
|
№1 / 2020
|
|
Rakitianskaya I.A., Riabova T.S., Kalashnikovа A.A.
Use of allokin-alpha in the treatment of chronic herpesvirus infection in adults
|
№4 / 2019
|
|
Klimova R.R., Sotnikov I.A., Chichev E.V., Egorova N.Yu., Okolysheva N.V., Kisteneva L.B., Uchaikin V.F., Kushch A.A.
Comparative analysis of the frequency of herpesvirus infection markers in clinical samples from children with various infectious diseases
|
№4 / 2014
|
Русский
